Monday, September 30, 2024

September 30, 2024 at 10:30PM Biological Product Deviation Reporting and HCT/P Deviation Reporting -- Deviation Codes

Use the following list of Biological Product Deviation (BPD) Codes to assign a specific code to a reportable event when you submit the report to FDA. Use the guidance document, "Biological Product Deviation Reporting for Blood and Plasma Establishments," (https://ift.tt/hDxW6nQ) to determ

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/slXL4qS

September 30, 2024 at 07:04PM Center for Biologics Evaluation and Research (CBER) Product Approval Information

Center for Biologics Evaluation and Research (CBER) Product Approval Information

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/tQuWUzq

September 27, 2024 at 06:13PM Fluzone Quadrivalent, Fluzone High-Dose Quadrivalent, Fluzone, Intradermal Quadrivalent, Fluzone Quadrivalent Southern Hemisphere, Fluzone High-Dose Quadrivalent Southern Hemisphere

For active immunization of persons 6 months of age and older for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/HnXD5yJ

September 25, 2024 at 07:19PM Antimicrobial Resistance Information from FDA

Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem. Learn what FDA is doing to address AMR.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/eodGTnp

September 25, 2024 at 03:57PM An Acceptable Circular of Information for the Use of Human Blood and Blood Components

This is the final guidance An Acceptable Circular of Information for the Use of Human Blood and Blood Components.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/uSAdRjg

September 25, 2024 at 03:54PM Blood Guidances

This page contains a listing of Blood Guidances guidances.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Dm5IMSd

Tuesday, September 24, 2024

September 24, 2024 at 10:07PM FDA Roundup: September 24, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/lYiSnL1

Monday, September 23, 2024

September 23, 2024 at 05:25PM Workshop on Integration Site Analysis During Long Term Follow-Up for Gene Therapies with Integrating Viral Vectors - 11/14/2024

The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a virtual scientific public workshop on the clinical use of integration site analysis (ISA) during long term follow-up following administration of gene therapies with integrating viral vectors.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/35HvdwQ

September 23, 2024 at 03:12PM Biologics PREA Reviews and Labeling Changes

PREA Labeling Changes, Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505B of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA). These assessments are for CBER regulated drugs approved under

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Smr2F98

Friday, September 20, 2024

September 20, 2024 at 11:56PM FluMist

For the active immunization of individuals 2-49 years of age against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Usk4XKP

September 20, 2024 at 03:05PM Basic Safety and Essential Performance of Medical Electrical Equipment, Medical Electrical Systems, and Laboratory Medical Equipment - Standards Specific Information for the Accreditation Scheme for Conformity Assessment (ASCA) Program

ASCA Program; Basic Safety and Essential Performance Standards Specific Testing for ASCA; Biocompatibility Standards Specific Testing for ASCA

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/IxfMnj0

September 20, 2024 at 03:05PM The Accreditation Scheme for Conformity Assessment (ASCA) Program

Guidance: ASCA Program; Basic Safety and Essential Performance Standards Specific Testing for ASCA; Biocompatibility Standards Specific Testing for ASCA

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/YsSNq7P

September 19, 2024 at 09:10PM OTP Events, Meetings, and Workshops

Office of Therapeutic Products Events, Meetings, and Workshops

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/cGHBSpA

September 19, 2024 at 03:54PM Center for Biologics Evaluation and Research & Center for Drug Evaluation and Research Real-World Evidence

As defined by FDA, real-world data (RWD) are the data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources and real-world evidence (RWE) is the clinical evidence regarding a medical product’s use and potential benefits or risks derived fr

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/bYoQm02

September 19, 2024 at 03:01PM Chemical Analysis for Biocompatibility Assessment of Medical Devices

This draft guidance document provides the FDA’s recommendations on analytical chemistry testing to assess the biocompatibility of medical devices.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/7a2FnMH

Wednesday, September 18, 2024

September 18, 2024 at 08:07PM Roster of the Blood Products Advisory Committee

This is the Roster of the Blood Products Advisory Committee (BPAC).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/bM6c9ps

September 18, 2024 at 03:31PM eSubmitter Application History

History of all updates to the application software in reverse chronological order by version number

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/snkog8W

September 18, 2024 at 01:55PM Coronavirus (COVID-19) | CBER-Regulated Biologics

This page and the associated links provide information on guidance and advice relevant to the development of therapies to treat or prevent COVID-19, and contact information for developers seeking additional information or assistance.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/uW7zjqc

September 18, 2024 at 01:45PM Information About the Updated COVID-19 Vaccines

The Fall respiratory virus season is here, and people may have questions about the safety and effectiveness of the updated COVID-19 vaccines.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/SIHTpWn

Tuesday, September 17, 2024

September 17, 2024 at 08:33PM FDA Roundup: September 17, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/xCBzJ9y

September 17, 2024 at 05:33PM Workshops, Meetings & Conferences (Biologics)

Information on CBER sponsored or co-sponsored meetings, conferences and workshops about various biologics in order to educate the public and seek the opinion of interested parties.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/zTBCYd1

September 17, 2024 at 05:28PM Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants - 10/25/2024

FDA, CDC and NIH are hosting a public workshop entitled “Live Biotherapeutic Products to Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants.”

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/XVF3YP7

Monday, September 16, 2024

September 16, 2024 at 05:33PM Study Data Technical Conformance Guide - Technical Specifications Document

This technical specifications document represents the Food and Drug Administration's (FDA's) current thinking on this topic.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2k4TiEs

September 16, 2024 at 12:53PM CBER-Regulated Products with Supporting Documents

CBER-Regulated Products with Supporting Documents is arranged alphabetically by the proper name of the product(s). Information is provided for original product approvals, new indications, and the current package insert.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/M9ou1mv

September 13, 2024 at 08:44PM Contacts in the Center for Biologics Evaluation & Research (CBER)

List of contact information in the Center for Biologics Evaluation & Research (CBER)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/OiCthPJ

September 13, 2024 at 06:13PM Types of FDA Inspections

The FDA conducts several types of inspections to help provide access to needed medical products and to protect consumers and patients from unsafe products:

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/WfOGjsg

Thursday, September 12, 2024

September 12, 2024 at 06:53PM HEPLISAV-B

Indicated for prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/iXZ6Fp8

September 12, 2024 at 03:42PM Join FDA for the First National Hispanic/Latino Family Cancer Awareness Week, Sept. 20-26

Project Community within the U.S. Food and Drug Administration’s Oncology Center of Excellence (OCE) will hold the first National Hispanic/Latino Family Cancer Awareness Week Sept. 20-26, 2024, to increase cancer awareness within the Hispanic/Latino population.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/XwFV13J

September 12, 2024 at 03:30PM Application Submissions Guidances

This page lists Application Submissions Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/kfNdZpe

September 11, 2024 at 03:03PM FDA Rare Disease Innovation Hub

FDA created the Rare Disease Innovation Hub (the Hub) to serve as a point of collaboration and connectivity between CBER and CDER with the goal of ultimately improving outcomes for patients.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2crPJsq

Tuesday, September 10, 2024

September 10, 2024 at 09:32PM FDA Roundup: September 10, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2puOLnQ

September 10, 2024 at 08:46PM Drugs@FDA Data Files

Drugs@FDA Downloadable Data File in ZIP format, Data Definitions, and Entity Relationship Diagram (ERD)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/kJ4cT1q

Monday, September 9, 2024

September 09, 2024 at 10:46PM OTP Town Hall: Cell Therapy CMC Readiness for Late-Stage INDs - 09/05/2024

The focus of this virtual town hall was to answer questions related to CMC data and information needed to support late-stage INDs for cell therapy and tissue-engineered products.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/AYB3xNH

September 09, 2024 at 07:35PM Incorporating Voluntary Patient Preference Information over the Total Product Life Cycle

Revision to the 2016 Patient Preference Guidance

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/hlsQgvc

September 05, 2024 at 05:26PM Developing and Evaluating Animal Models for Studying the Safety and Efficacy of Vaccines Against Anthrax, Staphylococcal Infections, and Pertussis

A description of Tod Merkel's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/FB20YCj

Friday, September 6, 2024

September 06, 2024 at 02:00PM Vaccines and Related Biological Products Advisory Committee September 20, 2024 Meeting Announcement - 09/20/2024

This is the main page for the CBER Vaccines and Related Biological Products Advisory Committee (VRBPAC) September 20, 2024 Meeting announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/JBHPCwg

Thursday, September 5, 2024

September 06, 2024 at 06:00AM Jobs at the Center for Biologics Evaluation and Research (CBER)

CBER has unique opportunities for individuals with backgrounds in science or administration to fill positions involved in the regulation and research of blood, vaccines and therapeutics.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/M7JjW4i

September 06, 2024 at 02:22AM Health Fraud Scams

Learn how to spot health fraud and avoid it.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/bkxunBR

September 05, 2024 at 11:39PM ACAM2000

ACAM2000 is a product approval indicated for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/0dtBylg

September 05, 2024 at 02:50PM Incorporating Voluntary Patient Preference Information over the Total Product Life Cycle

Revision to the 2016 Patient Preference Guidance

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/aVLoWDZ

Wednesday, September 4, 2024

September 04, 2024 at 10:57PM Studies on Safety and Efficacy of Platelets and Other Transfused Blood Products

A description of J.G. Vostal's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/CbAgmR2

September 04, 2024 at 07:46PM Diagnosis and Pathogenesis of Hepatitis Viruses That Impact the Safety of Blood and Related Products

David R. McGivern's research project "Diagnosis and Pathogenesis of Hepatitis Viruses That Impact the Safety of Blood and Related Products".

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ozTiVD8

Tuesday, September 3, 2024

September 04, 2024 at 12:26AM ABRYSVO

ABRYSVO is indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older, and pregnant individuals at 32 through 36 weeks gestational age.


via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/1dcN5BP

September 03, 2024 at 09:32PM KYMRIAH

KYMRIAH is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ftJ8N0p

September 03, 2024 at 09:02PM La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente

La FDA autorizó para uso de emergencia la vacuna contra el COVID-19 de Novavax actualizada (fórmula 2024-2025) con el fin de atacar más de cerca las variantes que circulan actualmente y brindar una mejor protección contra las consecuencias graves del COVID-19.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/hkqlTwu

September 03, 2024 at 03:20PM Mother Stem Institute, Corp. - 680118 - 08/20/2024

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/yg6ceqO